{"transactions":[{"id":740514,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":38971,"kind":"person","name":"Dong Linda","position":1,"cik":"0001765204","reported_name":"Dong Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T20:19:13.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":4525,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,525 shares of restricted stock, which will vest on the earlier of June 10, 2027 or the date of the Issuer's 2027 annual meeting of stockholders."}],"balance_after":97133,"source":{"system":"sec-edgar","filing":"0001104659-26-073484","document":"tm2617575-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465926073484/tm2617575-3_4seq1.xml","form_type":"4"}},{"id":775052,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":38971,"kind":"person","name":"Dong Linda","position":1,"cik":"0001765204","reported_name":"Dong Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T22:30:39.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":11117,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after May 14, 2026, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date."}],"balance_after":38758,"source":{"system":"sec-edgar","filing":"0001765204-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000176520426000004/ownership.xml","form_type":"4"}},{"id":1007177,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":38971,"kind":"person","name":"Dong Linda","position":1,"cik":"0001765204","reported_name":"Marsh Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to Buy)","published_at":"2025-11-06T00:44:13.000Z","date":"2025-11-03","kind":"exercise","planned":false,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These stock options were fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":18.2,"expiration_date":"2025-11-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-25-107189","document":"tm2530332-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465925107189/tm2530332-1_4seq1.xml","form_type":"4"}},{"id":1007176,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":38971,"kind":"person","name":"Dong Linda","position":1,"cik":"0001765204","reported_name":"Marsh Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-06T00:44:13.000Z","date":"2025-11-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":11033,"price":32.99,"value":363978.67,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,449 shares of restricted stock, which will vest on the earlier of June 11, 2026 or the date of the Issuer's 2026 annual meeting of stockholders."}],"balance_after":92608,"source":{"system":"sec-edgar","filing":"0001104659-25-107189","document":"tm2530332-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465925107189/tm2530332-1_4seq1.xml","form_type":"4"}},{"id":1007175,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":38971,"kind":"person","name":"Dong Linda","position":1,"cik":"0001765204","reported_name":"Marsh Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-06T00:44:13.000Z","date":"2025-11-03","kind":"exercise","planned":false,"acquired":true,"shares":20000,"price":18.2,"value":364000.0,"ownership":{"direct":true},"balance_after":103641,"source":{"system":"sec-edgar","filing":"0001104659-25-107189","document":"tm2530332-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465925107189/tm2530332-1_4seq1.xml","form_type":"4"}},{"id":1112297,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":38971,"kind":"person","name":"Dong Linda","position":1,"cik":"0001765204","reported_name":"Marsh Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-13T20:20:39.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":6449,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) June 11, 2026 or (ii) the date of the Issuer's 2026 annual meeting of stockholders."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 6,449 shares of restricted stock, which will vest on the earlier of June 11, 2026 or the date of the Issuer's 2026 annual meeting of stockholders."}],"balance_after":83641,"source":{"system":"sec-edgar","filing":"0001104659-25-059377","document":"tm2517874-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465925059377/tm2517874-5_4seq1.xml","form_type":"4"}},{"id":1142736,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":38971,"kind":"person","name":"Dong Linda","position":1,"cik":"0001765204","reported_name":"Marsh Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T23:29:07.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":8982,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after May 15, 2025, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date."}],"balance_after":27641,"source":{"system":"sec-edgar","filing":"0000950170-25-074718","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000095017025074718/ownership.xml","form_type":"4"}},{"id":1409074,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":38971,"kind":"person","name":"Dong Linda","position":1,"cik":"0001765204","reported_name":"Marsh Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-09-12T21:03:41.000Z","date":"2024-09-10","kind":"exercise","planned":false,"acquired":false,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options were fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":15.35,"expiration_date":"2024-10-11","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001104659-24-099376","document":"tm2423950-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465924099376/tm2423950-1_4seq1.xml","form_type":"4"}},{"id":1409073,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":38971,"kind":"person","name":"Dong Linda","position":1,"cik":"0001765204","reported_name":"Marsh Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-12T21:03:41.000Z","date":"2024-09-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":3522,"price":47.93,"value":168809.46,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,650 shares of restricted stock, which will vest on December 9, 2024, and 3,564 shares of restricted stock, which will vest on the earlier of August 13, 2025 or the date of the Issuer's 2025 annual meeting of stockholders."}],"balance_after":77192,"source":{"system":"sec-edgar","filing":"0001104659-24-099376","document":"tm2423950-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465924099376/tm2423950-1_4seq1.xml","form_type":"4"}},{"id":1409072,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":38971,"kind":"person","name":"Dong Linda","position":1,"cik":"0001765204","reported_name":"Marsh Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-12T21:03:41.000Z","date":"2024-09-10","kind":"exercise","planned":false,"acquired":true,"shares":11000,"price":15.35,"value":168850.0,"ownership":{"direct":true},"balance_after":80714,"source":{"system":"sec-edgar","filing":"0001104659-24-099376","document":"tm2423950-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465924099376/tm2423950-1_4seq1.xml","form_type":"4"}},{"id":1434085,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":38971,"kind":"person","name":"Dong Linda","position":1,"cik":"0001765204","reported_name":"Marsh Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-14T20:39:36.000Z","date":"2024-08-13","kind":"grant","planned":false,"acquired":true,"shares":3564,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) August 13, 2025 or (ii) the date of the Issuer's 2025 annual meeting of stockholders."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,650 shares of restricted stock, which will vest on December 9, 2024, and 3,564 shares of restricted stock, which will vest on the earlier of August 13, 2025 or the date of the Issuer's 2025 annual meeting of stockholders."}],"balance_after":69714,"source":{"system":"sec-edgar","filing":"0001104659-24-089699","document":"tm2421691-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465924089699/tm2421691-6_4seq1.xml","form_type":"4"}},{"id":1508994,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":38971,"kind":"person","name":"Dong Linda","position":1,"cik":"0001765204","reported_name":"Marsh Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-20T22:04:23.000Z","date":"2024-05-16","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after May 16, 2024, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date."}],"balance_after":18659,"source":{"system":"sec-edgar","filing":"0000950170-24-062569","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000095017024062569/ownership.xml","form_type":"4"}},{"id":1707943,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":38971,"kind":"person","name":"Dong Linda","position":1,"cik":"0001765204","reported_name":"Marsh Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-18T21:36:53.000Z","date":"2023-12-15","kind":"grant","planned":false,"acquired":true,"shares":3650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan, which shall vest on December 9, 2024 (or if earlier, upon the date of the Reporting Person's cessation of service on the Issuer's board of directors)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,650 shares of restricted stock, which will vest on December 9, 2024."}],"balance_after":66150,"source":{"system":"sec-edgar","filing":"0001104659-23-126904","document":"tm2333076-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465923126904/tm2333076-6_4seq1.xml","form_type":"4"}},{"id":1882672,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":38971,"kind":"person","name":"Dong Linda","position":1,"cik":"0001765204","reported_name":"Marsh Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-22T20:38:36.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":5059,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after May 18, 2023, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date."}],"balance_after":10659,"source":{"system":"sec-edgar","filing":"0001209191-23-031477","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919123031477/doc4.xml","form_type":"4"}},{"id":1952651,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":38971,"kind":"person","name":"Dong Linda","position":1,"cik":"0001765204","reported_name":"Marsh Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-15T20:32:52.000Z","date":"2023-03-14","kind":"disposition_to_issuer","acquired":false,"shares":270081,"price":35.32,"value":9539260.92,"ownership":{"direct":false,"nature":"Alliance Apex, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are owned directly by Alliance Apex, LLC, of which Reporting Person is a member and the sole manager. Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein, and the filing of this report is not an admission that Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001628280-23-008109","document":"wf-form4_167891236085499.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000162828023008109/wf-form4_167891236085499.xml","form_type":"4"}},{"id":1957312,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":38971,"kind":"person","name":"Dong Linda","position":1,"cik":"0001765204","reported_name":"Marsh Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-13T16:40:54.000Z","date":"2023-03-09","kind":"exercise","acquired":false,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options were granted on March 4, 2020 and vested and became exercisable on the date of the grant."}],"balance_after":0,"derivative":{"exercise_price":10,"expiration_date":"2023-04-05","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001250853-23-000009","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000125085323000009/primary_doc.xml","form_type":"4"}},{"id":1957311,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":38971,"kind":"person","name":"Dong Linda","position":1,"cik":"0001765204","reported_name":"Marsh Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-13T16:40:54.000Z","date":"2020-03-04","kind":"grant","acquired":true,"shares":62500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported on Lines 1 and 2 involved an amendment of an outstanding option, resulting in the cancellation of the original option and the grant of a replacement option. The option was originally granted on April 5, 2017 and vested and became exercisable on a monthly basis over thirty six months commencing on May 5, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported on Lines 1 and 2 involved an amendment of an outstanding option, resulting in the cancellation of the original option and the grant of a replacement option. The option was originally granted on April 5, 2017 and vested and became exercisable on a monthly basis over thirty six months commencing on May 5, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The transactions reported on Lines 1 and 2 involved an amendment of an outstanding option, resulting in the cancellation of the original option and the grant of a replacement option. The option was originally granted on April 5, 2017 and vested and became exercisable on a monthly basis over thirty six months commencing on May 5, 2017."}],"balance_after":62500,"derivative":{"exercise_price":10,"expiration_date":"2023-04-05","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001250853-23-000009","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000125085323000009/primary_doc.xml","form_type":"4"}},{"id":1957310,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":38971,"kind":"person","name":"Dong Linda","position":1,"cik":"0001765204","reported_name":"Marsh Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-13T16:40:54.000Z","date":"2020-03-04","kind":"disposition_to_issuer","acquired":false,"shares":62500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported on Lines 1 and 2 involved an amendment of an outstanding option, resulting in the cancellation of the original option and the grant of a replacement option. The option was originally granted on April 5, 2017 and vested and became exercisable on a monthly basis over thirty six months commencing on May 5, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported on Lines 1 and 2 involved an amendment of an outstanding option, resulting in the cancellation of the original option and the grant of a replacement option. The option was originally granted on April 5, 2017 and vested and became exercisable on a monthly basis over thirty six months commencing on May 5, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The transactions reported on Lines 1 and 2 involved an amendment of an outstanding option, resulting in the cancellation of the original option and the grant of a replacement option. The option was originally granted on April 5, 2017 and vested and became exercisable on a monthly basis over thirty six months commencing on May 5, 2017."}],"balance_after":0,"derivative":{"exercise_price":10,"expiration_date":"2020-04-05","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001250853-23-000009","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000125085323000009/primary_doc.xml","form_type":"4"}},{"id":1957309,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":38971,"kind":"person","name":"Dong Linda","position":1,"cik":"0001765204","reported_name":"Marsh Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-13T16:40:54.000Z","date":"2023-03-09","kind":"exercise","acquired":true,"shares":62500,"price":10,"value":625000.0,"ownership":{"direct":true},"balance_after":62500,"source":{"system":"sec-edgar","filing":"0001250853-23-000009","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000125085323000009/primary_doc.xml","form_type":"4"}},{"id":2195812,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":38971,"kind":"person","name":"Dong Linda","position":1,"cik":"0001765204","reported_name":"Marsh Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-03T21:42:07.000Z","date":"2022-08-01","kind":"grant","acquired":true,"shares":1600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after August 1, 2022, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date."}],"balance_after":5600,"source":{"system":"sec-edgar","filing":"0001209191-22-044294","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919122044294/doc4.xml","form_type":"4"}},{"id":2228652,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":38971,"kind":"person","name":"Dong Linda","position":1,"cik":"0001765204","reported_name":"Marsh Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-18T00:26:03.000Z","date":"2022-06-17","kind":"sale","acquired":false,"shares":250000,"price":37,"value":9250000.0,"ownership":{"direct":false,"nature":"Held by Alliance Apex, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are owned directly by Alliance Apex, LLC, of which Reporting Person is a member and the sole manager. Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein, and the filing of this report is not an admission that Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose."}],"balance_after":270081,"source":{"system":"sec-edgar","filing":"0001104659-22-072514","document":"tm2218854d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465922072514/tm2218854d2_4.xml","form_type":"4"}},{"id":2261860,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":38971,"kind":"person","name":"Dong Linda","position":1,"cik":"0001765204","reported_name":"Marsh Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-20T20:04:45.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after May 18, 2022, and 1/16th of such shares vesting at the end of every three-month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date."}],"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001209191-22-030961","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919122030961/doc4.xml","form_type":"4"}},{"id":2428041,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":38971,"kind":"person","name":"Dong Linda","position":1,"cik":"0001765204","reported_name":"Marsh Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-24T23:01:01.000Z","date":"2022-01-20","kind":"grant","acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal quarterly installments from January 18, 2022."}],"balance_after":8500,"derivative":{"exercise_price":53.01,"expiration_date":"2025-01-18","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001250853-22-000030","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000125085322000030/primary_doc.xml","form_type":"4"}},{"id":2699013,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":38971,"kind":"person","name":"Dong Linda","position":1,"cik":"0001765204","reported_name":"Marsh Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-24T21:26:43.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an award of restricted stock units relating to 2,000 shares of the Issuer's common stock. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after May 20, 2021, and 1/16th of such shares vesting every three months over the remaining 36 months, subject to the reporting person's continued service for Issuer on each vesting date."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001209191-21-035452","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919121035452/doc4.xml","form_type":"4"}},{"id":2981801,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":38971,"kind":"person","name":"Dong Linda","position":1,"cik":"0001765204","reported_name":"Marsh Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-14T01:39:29.000Z","date":"2020-11-11","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal quarterly installments from the option grant date."}],"balance_after":20000,"derivative":{"exercise_price":18.2,"expiration_date":"2025-11-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001250853-20-000105","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000125085320000105/primary_doc.xml","form_type":"4"}},{"id":3132297,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":38971,"kind":"person","name":"Dong Linda","position":1,"cik":"0001765204","reported_name":"Marsh Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-28T16:42:02.000Z","date":"2020-05-27","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after May 27, 2020, and 1/16th of such shares  vesting at the end of every three-month period over the 36 months thereafter, subject to Ms. Marsh's continued service for the Issuer on each vesting date."}],"balance_after":5000,"derivative":{"exercise_price":15.82,"expiration_date":"2030-05-26","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-20-032548","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919120032548/doc4.xml","form_type":"4"}},{"id":3364628,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":38971,"kind":"person","name":"Dong Linda","position":1,"cik":"0001765204","reported_name":"Marsh Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-11-20T19:20:02.000Z","date":"2019-10-11","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Issuer granted these options to Reporting Person in consideration for her service as a director of the Issuer. Such stock options vest in 4 installments on January 11, 2020; April 11, 2020; July 11, 2020; and October 11, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Issuer granted these options to Reporting Person in consideration for her service as a director of the Issuer. Such stock options vest in 4 installments on January 11, 2020; April 11, 2020; July 11, 2020; and October 11, 2020."}],"balance_after":73500,"derivative":{"exercise_price":15.35,"exercise_date":"2020-01-11","expiration_date":"2024-10-11","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001104659-19-065776","document":"tm1923454d5_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465919065776/tm1923454d5_4.xml","form_type":"4"}},{"id":3447197,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":38971,"kind":"person","name":"Dong Linda","position":1,"cik":"0001765204","reported_name":"Marsh Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-05T13:17:01.000Z","date":"2019-08-01","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after August 1, 2019, and 1/16th of the remaining shares vesting at the end of every three-month period over the remaining 36 months, subject to Ms. Marsh's continued service for the Predecessor or the Issuer on each vesting date."}],"balance_after":20000,"derivative":{"exercise_price":7.56,"expiration_date":"2029-08-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-19-044388","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919119044388/doc4.xml","form_type":"4"}}]}